Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07540533 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer

Name: A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast Cancer — clinical trial record (NCT07540533)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: 2025-370

StatusRecruiting

PhasePhase 2

SponsorHenan Cancer Hospital

Started2026-01-20

View on ClinicalTrials.gov ↗

Henan Cancer Hospital

107 trials monitored

See 2 trials at risk

Breast Cancer

5,180 trials monitored

See 256 trials at risk

To evaluate the efficacy and safety of toripalimab in combination with investigator-selected chemotherapy in patients with recurrent or metastatic HER2-negative breast cancer who have failed prior systemic therapy.

Trial Details

NCT Number	NCT07540533
Lead Sponsor	Henan Cancer Hospital
Conditions	Advanced Breast Cancer
Enrollment	92 participants
Start Date	2026-01-20
Primary Completion	2027-08 (estimated)
Study Completion	2028-08 (estimated)
Updated on ClinicalTrials.gov	2026-04-20